SM04690 Promising for Knee OA

SM04690, an intra-articular injection for knee OA, will soon enter phase 3 trials to assess its effects on pain, joint function and disease...

Source: The Rheumatologist - March 27, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Drug Updates disease-modifying osteoarthritis drug (DMOAD) joint injection knee Knee Osteoarthritis (OA) SM04690 Source Type: research